Carter Robert Ross 4
4 · Oncology Institute, Inc. · Filed Nov 21, 2024
Insider Transaction Report
Form 4
Carter Robert Ross
Chief Financial Officer
Transactions
- Disposition to Issuer
Class A Common Stock
2024-11-20$0.14/sh−235$32→ 31,759 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
- [F2]Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.136 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.